Julia Yunus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia Yunus has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Haryati Jamaluddin
Department of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, Skudai, Malaysia
1 shared publication - Khairunadwa Jemon
Department of Biosciences, Faculty of Science, Universiti Teknologi Malaysia
1 shared publication - Mohd Anuar Jonet
Structural And Applied Genomics Centre, Malaysia Genome and Vaccine Institute (MGVI), National Institute of Biotechnology Malaysia (NIBM)
1 shared publication - Shaza Eva Mohamad
Department of Environmental Engineering and Green Technology (EGT), Malaysia Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia, Jalan, Sultan Yahya Petra
1 shared publication - Wan Rosmiza Zana Wan Dagang
Faculty of Science, Universiti Teknologi Malaysia, Johor, Malaysia
1 shared publication
Latest Publications
- 18 June 2026
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 52 (5) , 1-17
Protease-driven approaches for wound eschar debridement and biofilm disruption: current advances, future prospects, and limitations
Chronic wounds frequently develop eschar, a dense layer of necrotic tissue that impedes healing and fosters bacterial biofilm formation. Biofilms, protected within an extracellular polymeric substance, show high resistance to antimicrobial agents, making wound management challenging. Conventional surgical debridement, though effective, is invasive, painful, and damages healthy tissue. Enzymatic debridement using proteolytic enzymes provides a less invasive, selective alternative. This review summarizes advances in protease-based therapies from plant, bacterial, and recombinant sources, focusing on their dual role in degrading eschar proteins and disrupting biofilm architecture. By elucidating the mechanisms through which proteases hydrolyze structural proteins and dismantle biofilms, we highlight their potential as minimally invasive interventions that enhance healing, reduce infection, and improve patient outcomes.
- 18 June 2026
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 52 (5) , 1-17
Protease-driven approaches for wound eschar debridement and biofilm disruption: current advances, future prospects, and limitations
Chronic wounds frequently develop eschar, a dense layer of necrotic tissue that impedes healing and fosters bacterial biofilm formation. Biofilms, protected within an extracellular polymeric substance, show high resistance to antimicrobial agents, making wound management challenging. Conventional surgical debridement, though effective, is invasive, painful, and damages healthy tissue. Enzymatic debridement using proteolytic enzymes provides a less invasive, selective alternative. This review summarizes advances in protease-based therapies from plant, bacterial, and recombinant sources, focusing on their dual role in degrading eschar proteins and disrupting biofilm architecture. By elucidating the mechanisms through which proteases hydrolyze structural proteins and dismantle biofilms, we highlight their potential as minimally invasive interventions that enhance healing, reduce infection, and improve patient outcomes.